Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CP 0127

Known as: CP-0127 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Early pharmacological treatment has the potential to reduce some of the disabling cognitive and behavioral problems that result… Expand
Is this relevant?
1998
1998
Summary Focal cerebral contusions can be dynamic and expansive, leading to delayed neurological deterioration. Due to the high… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 4
Is this relevant?
Highly Cited
1997
Highly Cited
1997
OBJECTIVE To test the effect of a novel bradykinin antagonist, deltibant (CP-0127), on survival, organ dysfunction, and other… Expand
Is this relevant?
1997
1997
Abstract To test the effect of a novel bradykinin antagonist, deltibant (CP-0127), on survival, organ dysfunction, and other… Expand
Is this relevant?
1997
1997
Isolated rabbit hearts in a modified Langendorff preparation were used to study the role of bradykinin B2-receptor antagonism on… Expand
Is this relevant?
1996
1996
In order to investigate the contribution of kinin receptor antagonism in the treatment of LPS-induced shock we conducted a… Expand
Is this relevant?
1994
1994
We studied the effects of CP-0127, a novel bradykinin receptor antagonist, in a rat model of traumatic shock. Pentobarbital… Expand
Is this relevant?
1992
1992
The bradykinin antagonist dimer CP-0127 was found to be a potent and selective inhibitor of the depressor response to bradykinin… Expand
Is this relevant?